We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,825 results
  1. Brusatol sensitizes endometrial hyperplasia and cancer to progestin by suppressing NRF2-TET1-AKR1C1-mediated progestin metabolism

    Progestin resistance is the main obstacle for the conservative therapy to maintain fertility in women with endometrial cancer. Brusatol was...

    Meiyan Hu, Di Sun, ... Zhenbo Zhang in Laboratory Investigation
    Article 29 August 2022
  2. Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases

    Objective

    This study aimed to evaluate the oncological and reproductive outcomes of fertility-preserving re-treatment in progestin-resistant...

    Junyu Chen, Dongyan Cao in World Journal of Surgical Oncology
    Article Open access 25 June 2024
  3. The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding controlā€”plus more

    The interlink between bleeding control and contraceptive development has always been an important factor. But after many years of advances in...

    Article Open access 09 October 2023
  4. In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer

    Progestin-only based oral contraceptives are majorly used as ā€˜minipillā€™ to prevent unintended pregnancy and treat conditions like polycystic ovary...

    Anuradha Sharma, Indu Sharma in Medical Oncology
    Article 03 June 2023
  5. Meningioma in patients exposed to progestin drugs: results from a real-life screening program

    Purpose

    To report the results of systematic meningioma screening program implemented by French authorities in patients exposed to progestin therapies...

    Thomas Samoyeau, Corentin Provost, ... Joseph Benzakoun in Journal of Neuro-Oncology
    Article 06 September 2022
  6. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF

    Background

    To explore if exogenous progestin required for progestin primed ovarian stimulation (PPOS) protocol compromises the euploidy rate of...

    Angel Hsin-Yu Pai, Yen Ju Sung, ... Chia Lin Chang in Reproductive Biology and Endocrinology
    Article Open access 08 August 2023
  7. GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis

    Purpose

    The aim of this meta-analysis was comparing the efficacy of GnRH antagonist (GnRH-ant) protocol and progestin-primed ovarian stimulation...

    Renhe Deng, **yuan Wang, ... **aocan Lei in Archives of Gynecology and Obstetrics
    Article 13 November 2023
  8. Comparison of fixed and flexible progestin-primed ovarian stimulation protocols to prevent premature luteinization in patients with diminished ovarian reserve

    Purpose

    Flexible progestin-primed ovarian stimulation (PPOS) protocol is demonstrated to be effective in suppressing premature luteinization in few...

    GĆ¼lşen Doğan Durdağ, Pınar Ƈağlar AytaƧ, ... Erhan Şimşek in Archives of Gynecology and Obstetrics
    Article 13 May 2023
  9. Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol

    Prediction of individual ovarian response to exogenous gonadotropin is a cornerstone for success and safety in all controlled ovarian stimulation...

    Shuxie Wu, Yan** Li, ... Hanbin Wu in BMC Women's Health
    Article Open access 28 April 2023
  10. Progestin-related WHO grade II meningiomas behaviorā€”a single-institution comparative case series

    WHO grade II progestin-related meningiomas have been reported in recent series but we found no previous study describing their long-term outcome. Our...

    Antoine Devalckeneer, Rabih Aboukais, ... Jean-Paul Lejeune in Neurosurgical Review
    Article 30 November 2021
  11. Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol

    Background

    Gonadal hormones can modify immune function, which may impact susceptibility to infectious diseases, including Human Immunodeficiency Virus...

    Lisa B. Haddad, Gina Bailey Herring, ... Alicia K. Smith in BMC Women's Health
    Article Open access 18 November 2022
  12. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia

    Purpose

    This study aims to evaluate the efficacy of hysteroscopic curettage combined with progestin therapy in young patients with early-stage...

    Yong **, Geng Liu, ... Runqi Gong in Archives of Gynecology and Obstetrics
    Article 08 June 2022
  13. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation

    Background

    Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has...

    Haipeng Huang, Yukiko Itaya, ... Yasushi Takai in Journal of Ovarian Research
    Article Open access 04 January 2022
  14. Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol

    Background

    Progestins can suppress endogenous luteinising hormone (LH) secretion from the pituitary gland and have shown similar efficacy in terms of...

    Lu Wang, **gyun Wang, ... Ai Ai in European Journal of Medical Research
    Article Open access 16 January 2023
  15. Higher baseline heart rate variability in CCHS patients with progestin-associated recovery of hypercapnic ventilatory response

    After a fortuitous observation of two cases of chemosensitivity recovery in women with congenital central hypoventilation syndrome (CCHS) who took...

    Caroline Sevoz-Couche, Maxime Patout, ... Christian Straus in Respiratory Research
    Article Open access 09 February 2024
  16. Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study

    Objective

    To explore the efficacy of progestin-primed ovarian stimulation (PPOS) combined with clomiphene citrate (CC) versus PPOS protocol used alone...

    Ahui Liu, Jie Li, ... Xuehong Zhang in BMC Women's Health
    Article Open access 17 December 2022
  17. The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation

    Objective

    To explore the optimal models for predicting the formation of high-quality embryos in Poor Ovarian Response (POR) Patients with...

    Yu-Heng **ao, Yu-Lin Hu, ... Chang-Chun Niu in Reproductive Biology and Endocrinology
    Article Open access 10 July 2024
  18. Evolution of the neurosurgical management of progestinā€associated meningiomas: a 23-year singleā€center experience

    Purpose

    The improving knowledge of interactions between meningiomas and progestin refines the management of this specific condition. We assessed the...

    Henri Malaize, Thomas Samoyeau, ... Johan Pallud in Journal of Neuro-Oncology
    Article 15 January 2021
  19. Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice

    Purpose

    PAQR7 plays a key role in cell apoptosis as a progesterone membrane receptor. The physiological mechanism of PAQR7 in ovarian function and its...

    Jia Li, Yiting Liu, ... Tao Luo in Journal of Ovarian Research
    Article Open access 06 February 2024
Did you find what you were looking for? Share feedback.